GFAP and COVID-19: Studies on COVID-19 patients have highlighted critical brain injury biomarkers, such as neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and matrix metalloproteinase-9 (MMP-9), which are essential in understanding the extent of neural damage.